{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:46Z","timestamp":1791835846149,"version":"4.3.4"},"reference-count":323,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174354"],"award-info":[{"award-number":["82174354"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115669","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T20:08:36Z","timestamp":1696882116000},"page":"115669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs"],"prefix":"10.1016","volume":"168","author":[{"given":"Yutong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhe","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115669_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.biopha.2023.115669_bib2","first-page":"144","volume":"12","author":"Jia","year":"2016","journal-title":"Nihms-757267"},{"key":"10.1016\/j.biopha.2023.115669_bib3","article-title":"The role of posttranslational modification and mitochondrial quality control in cardiovascular diseases","volume":"2021","author":"Liu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115669_bib4","first-page":"1","article-title":"Mitochondrial dynamics and mitophagy in cardiometabolic disease","volume":"9","author":"Lin","year":"2022","journal-title":"Front. Cardiovasc. Med"},{"key":"10.1016\/j.biopha.2023.115669_bib5","first-page":"401","article-title":"Dairy outlook set to improve by early 2017 says ornua chief","volume":"102","author":"Dermody","year":"2016","journal-title":"Ir. Exam."},{"key":"10.1016\/j.biopha.2023.115669_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13167-021-00237-2","article-title":"Mitochondrial impairments in aetiopathology of multifactorial diseases: common origin but individual outcomes in context of 3P medicine","volume":"12","author":"Koklesova","year":"2021","journal-title":"EPMA J."},{"key":"10.1016\/j.biopha.2023.115669_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100940","article-title":"Mitochondria in the signaling pathways that control longevity and health span","volume":"54","author":"Akbari","year":"2019","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.biopha.2023.115669_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2023.115669_bib9","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1089\/ars.2015.6293","article-title":"Mitochondrial Dynamics in Diabetic Cardiomyopathy","volume":"22","author":"Galloway","year":"2015","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2023.115669_bib10","first-page":"1272","volume":"119","author":"Ph","year":"2010","journal-title":"Contrib. Impair. Myocard. Insul."},{"key":"10.1016\/j.biopha.2023.115669_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-016-0309-5","article-title":"PPARs modulate cardiac metabolism and mitochondrial function in diabetes","volume":"24","author":"Lee","year":"2017","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21186559","article-title":"Diabetes mellitus, mitochondrial dysfunction and ca2+-dependent permeability transition pore","volume":"21","author":"Belosludtsev","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib13","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"DMM Dis. Model. Mech."},{"key":"10.1016\/j.biopha.2023.115669_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0005-2728(85)90076-3","article-title":"Oxidative metabolism of Polytron versus Nagarse mitochondria in hearts of genetically diabetic mice","volume":"806","author":"Kuo","year":"1985","journal-title":"BBA - Bioenerg."},{"key":"10.1016\/j.biopha.2023.115669_bib15","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00047.2004","article-title":"Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes","volume":"287","author":"Shen","year":"2004","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.115669_bib16","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1021\/acs.jproteome.5b00128","article-title":"Comprehensive Metabolic Profiling of Age-Related Mitochondrial Dysfunction in the High-Fat-Fed ob\/ob Mouse Heart","volume":"14","author":"Wang","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biopha.2023.115669_bib17","unstructured":"D.C. Andersson, S. Zhang, J.T. Lanner, R. Wibom, A. Katz, J.D. Bruton, H. Westerblad, and ob \/ ob Cardiomyocytes, 56, 2007. https:\/\/doi.org\/10.2337\/db06\u20130739.ECC."},{"key":"10.1016\/j.biopha.2023.115669_bib18","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"Jiska Cohen-Mansfield","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2023.115669_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biocel.2016.09.018","article-title":"Diabetes impairs heart mitochondrial function without changes in resting cardiac performance","volume":"81","author":"Bombicino","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0201891","article-title":"Cardiomyocytes cultured on mechanically compliant substrates, but not on conventional culture devices, exhibit prominent mitochondrial dysfunction due to reactive oxygen species and insulin resistance under high glucose","volume":"13","author":"Morishima","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115669_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155313","article-title":"Mitochondrial quality control mechanisms as molecular targets in diabetic heart","volume":"137","author":"Chang","year":"2022","journal-title":"Metabolism"},{"issue":"2021)","key":"10.1016\/j.biopha.2023.115669_bib22","article-title":"SFRP2 Improves Mitochondrial Dynamics and Mitochondrial Biogenesis, Oxidative Stress, and Apoptosis in Diabetic Cardiomyopathy","author":"Ma","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115669_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2021.648399","article-title":"High glucose attenuates cardioprotective effects of glucagon-like peptide-1 through induction of mitochondria dysfunction via inhibition of \u03b2-arrestin-signaling","volume":"12","author":"Pan","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1253\/circj.CJ-13-1187","article-title":"Production of reactive oxygen species in the diabetic heart: Roles of mitochondria and NADPH oxidase","volume":"78","author":"Teshima","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2023.115669_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0735-1097(03)00625-9","article-title":"Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus","volume":"42","author":"Diamant","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib26","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1161\/01.CIR.0000072789.89096.10","article-title":"Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes","volume":"107","author":"Scheuermann-Freestone","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115669_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01207-7","article-title":"Three-dimensional structured illumination microscopy data of mitochondria and lysosomes in cardiomyoblasts under normal and galactose-adapted conditions","volume":"9","author":"Opstad","year":"2022","journal-title":"Sci. Data."},{"key":"10.1016\/j.biopha.2023.115669_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5543452","article-title":"The role of mitochondrial quality control in cardiac ischemia\/reperfusion injury","volume":"2021","author":"Huang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115669_bib29","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1016\/j.jmb.2018.07.027","article-title":"Mechanisms orchestrating mitochondrial dynamics for energy homeostasis","volume":"430","author":"Yu","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib30","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1038\/emboj.2009.255","article-title":"Mitochondrial kiss-and-run: Interplay between mitochondrial motility and fusion-fission dynamics","volume":"28","author":"Liu","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2023.115669_bib31","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMra1215233","article-title":"Mitochondrial Dynamics \u2014 Mitochondrial Fission and Fusion in Human Diseases","volume":"369","author":"Archer","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib32","doi-asserted-by":"crossref","first-page":"6535","DOI":"10.1242\/jcs.01565","article-title":"Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity","volume":"117","author":"Ishihara","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.embor.7400488","article-title":"Separate fusion of outer and inner mitochondrial membranes","volume":"6","author":"Malka","year":"2005","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib34","doi-asserted-by":"crossref","first-page":"15927","DOI":"10.1073\/pnas.0407043101","article-title":"OPA1 requires mitofusin 1 to promote mitochondrial fusion","volume":"101","author":"Cipolat","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115669_bib35","first-page":"9-9","article-title":"Cummins to form joint venture with Nproxx for hydrogen storage","volume":"2020","year":"2020","journal-title":"Fuel Cells Bull."},{"key":"10.1016\/j.biopha.2023.115669_bib36","first-page":"1","article-title":"Insights Into Mitochondrial Dynamics in Chlamydial Infection","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol"},{"key":"10.1016\/j.biopha.2023.115669_bib37","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1038\/s41586-019-1296-y","article-title":"Mitochondrial fission requires DRP1 but not dynamins","volume":"570","author":"Fonseca","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115669_bib38","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1083\/jcb.201610057","article-title":"Receptor-mediated Drp1 oligomerization on endoplasmic reticulum","volume":"216","author":"Ji","year":"2017","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00018-017-2603-0","article-title":"The ever-growing complexity of the mitochondrial fission machinery","volume":"75","author":"Pagliuso","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.tcb.2018.11.003","article-title":"Structural Insights into the Mechanism of Dynamin Superfamily Proteins","volume":"29","author":"Jimah","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1083\/jcb.200611064","article-title":"The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division","volume":"178","author":"Karbowski","year":"2007","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib42","doi-asserted-by":"crossref","first-page":"17783","DOI":"10.1074\/jbc.M901902200","article-title":"Translocation of SenP5 from the nucleoli to the mitochondria modulates DRP1-dependent fission during mitosis","volume":"284","author":"Zunino","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/CIRCRESAHA.119.315252","article-title":"Increased Drp1 Acetylation by Lipid Overload Induces Cardiomyocyte Death and Heart Dysfunction","volume":"126","author":"Hu","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.115669_bib44","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1126\/science.1171091","article-title":"\u03b2-Amyloid-related mitochondrial fission and neuronal injury","volume":"324","author":"Cho","year":"2009","journal-title":"Sci. (80-. )"},{"key":"10.1016\/j.biopha.2023.115669_bib45","doi-asserted-by":"crossref","first-page":"30024","DOI":"10.1074\/jbc.M112.390682","article-title":"Modulation of dynamin-related protein 1 (DRP1) function by increased O-linked-\u03b2-N-acetylglucosamine modification (O-GlcNAc) in cardiac myocytes","volume":"287","author":"Gawlowski","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib46","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1074\/jbc.M607279200","article-title":"Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission","volume":"282","author":"Taguchi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2020.04.015","article-title":"The role of Drp1 in mitophagy and cell death in the heart","volume":"142","author":"Tong","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010144","article-title":"Drp1-dependent mitochondrial fission plays critical roles in physiological and pathological progresses in mammals","volume":"18","author":"Hu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib49","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1152\/ajpheart.00368.2011","article-title":"Mitochondrial autophagy by bnip3 involves drp1-mediated mitochondrial fission and recruitment of parkin in cardiac myocytes","volume":"301","author":"Lee","year":"2011","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/CIRCULATIONAHA.113.008476","article-title":"Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients","volume":"130","author":"Montaigne","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115669_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu9121323","article-title":"Melatonin efficacy in obese leptin-deficient mice heart","volume":"9","author":"Stacchiotti","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.115669_bib52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.yexcr.2014.02.027","article-title":"Roles of mitochondrial fragmentation and reactive oxygen species in mitochondrial dysfunction and myocardial insulin resistance","volume":"323","author":"Watanabe","year":"2014","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2023.115669_bib53","unstructured":"T. False, T. Financial, A. Standards, U. States, Page 1 of 66 1, 3, 2015: 1\u201366."},{"key":"10.1016\/j.biopha.2023.115669_bib54","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1073\/pnas.0511154103","article-title":"Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology","volume":"103","author":"Yu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115669_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2023.115669_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2022.892643","article-title":"A ROCK1 Inhibitior Fasudil Alleviates Cardiomyocyte Apoptosis in Diabetic Cardiomyopathy by Inhibiting Mitochondrial Fission in a Type 2 Diabetes Mouse Model","volume":"13","author":"Fan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib57","doi-asserted-by":"crossref","first-page":"ra23","DOI":"10.1126\/scisignal.2005673","article-title":"Ca2+ signals regulate mitochondrial metabolism by stimulating CREB-mediated expression of the mitochondrial Ca2+ uniporter gene MCU","volume":"8","author":"Shanmughapriya","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.biopha.2023.115669_bib58","article-title":"High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy","volume":"12","author":"Wu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2023.115669_bib59","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1073\/pnas.0808249105","article-title":"Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria","volume":"105","author":"Cereghetti","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115669_bib60","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.00548.2011","article-title":"Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy","volume":"303","author":"Fricovsky","year":"2012","journal-title":"Am. J. Physiol. - Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-020-07064-z","article-title":"Spermine Protects Cardiomyocytes from High Glucose-Induced Energy Disturbance by Targeting the CaSR-gp78-Ubiquitin Proteasome System","volume":"35","author":"Wang","year":"2021","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2023.115669_bib62","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.7150\/thno.33684","article-title":"Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy","volume":"9","author":"Hu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115669_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15252\/embj.2020104705","article-title":"Molecular mechanisms and physiological functions of mitophagy","volume":"40","author":"Onishi","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2023.115669_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12915-017-0470-7","article-title":"PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol","volume":"16","author":"Sekine","year":"2018","journal-title":"BMC Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib65","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","article-title":"Parkin is recruited selectively to impaired mitochondria and promotes their autophagy","volume":"183","author":"Narendra","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib66","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1083\/jcb.201402104","article-title":"PINK1 phosphorylates ubiquitin to activate parkin E3 ubiquitin ligase activity","volume":"205","author":"Kane","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib67","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180108","article-title":"Phosphorylation of Parkin at serine 65 is essential for its activation in vivo","volume":"8","author":"McWilliams","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib68","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature24645","article-title":"Structure of PINK1 in complex with its substrate ubiquitin","volume":"552","author":"Schubert","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115669_bib69","doi-asserted-by":"crossref","first-page":"19630","DOI":"10.1074\/jbc.M110.209338","article-title":"Parkin mediates proteasome-dependent protein degradation and rupture of the outer mitochondrial membrane","volume":"286","author":"Yoshii","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ncb2012","article-title":"PINK1\/Parkin-mediated mitophagy is dependent on VDAC1 and p62\/SQSTM1","volume":"12","author":"Geisler","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nature14893","article-title":"The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy","volume":"524","author":"Lazarou","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115669_bib72","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1074\/jbc.M112.399345","article-title":"Modulation of serines 17 and 24 in the LC3-interacting region of Bnip3 determines pro-survival mitophagy versus apoptosis","volume":"288","author":"Zhu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00246-010-9876-5","article-title":"Bnip3 as a dual regulator of mitochondrial turnover and cell death in the myocardium","volume":"32","author":"Gustafsson","year":"2011","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib74","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/2211-5463.13307","article-title":"A brief overview of BNIP3L\/NIX receptor-mediated mitophagy","volume":"11","author":"Marinkovi\u0107","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.biopha.2023.115669_bib75","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s13238-020-00713-x","article-title":"BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy","volume":"11","author":"Li","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.biopha.2023.115669_bib76","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/embr.201438501","article-title":"ULK1 translocates to mitochondria and phosphorylates FUNDC1 to regulate mitophagy","volume":"15","author":"Wu","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib77","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.15252\/embj.201593102","article-title":"FUNDC 1 regulates mitochondrial dynamics at the ER \u2013mitochondrial contact site under hypoxic conditions","volume":"35","author":"Wu","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2023.115669_bib78","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.celrep.2018.12.050","article-title":"A Mammalian Mitophagy Receptor, Bcl2-L-13, Recruits the ULK1 Complex to Induce Mitophagy","volume":"26","author":"Murakawa","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms8527","article-title":"Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation","volume":"6","author":"Murakawa","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115669_bib80","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1096\/fj.201901735R","article-title":"FKBP8 LIRL-dependent mitochondrial fragmentation facilitates mitophagy under stress conditions","volume":"34","author":"Yoo","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.115669_bib81","doi-asserted-by":"crossref","first-page":"947","DOI":"10.15252\/embr.201643147","article-title":"FKBP8 recruits LC3A to mediate Parkin\u2010independent mitophagy","volume":"18","author":"Bhujabal","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib82","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41590-019-0324-2","article-title":"Listeria hijacks host mitophagy through a novel mitophagy receptor to evade killing","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biopha.2023.115669_bib83","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddv017","article-title":"The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1 \/ PARK2 pathway Research and Therapy for Neuro-Psycho-Diseases and College of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu 215021, China","author":"Gao","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.biopha.2023.115669_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep44373","article-title":"Nix restores mitophagy and mitochondrial function to protect against PINK1\/Parkin-related Parkinson\u2019s disease","volume":"7","author":"Koentjoro","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib85","doi-asserted-by":"crossref","first-page":"R73","DOI":"10.1016\/j.cub.2016.11.055","article-title":"Mitophagy: Permitted by Prohibitin","volume":"27","author":"Galluzzi","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib86","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10456-022-09835-8","article-title":"Molecular mechanisms of coronary microvascular endothelial dysfunction in diabetes mellitus: focus on mitochondrial quality surveillance","volume":"25","author":"Sun","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.biopha.2023.115669_bib87","author":"Hallakou-Bozec","year":"2021","journal-title":"Mech. Action Imeglimin: A Nov. Ther. Agent Type 2 Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/cells8030213","article-title":"Notoginsenoside R1 ameliorates diabetic retinopathy through PINK1\u2013dependent activation of mitophagy","volume":"8","author":"Zhou","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115669_bib89","doi-asserted-by":"crossref","first-page":"H32","DOI":"10.1152\/ajpheart.00027.2017","article-title":"Desmin loss and mitochondrial damage precede left ventricular systolic failure in volume overload heart failure","volume":"313","author":"Guichard","year":"2017","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib90","doi-asserted-by":"crossref","first-page":"18077","DOI":"10.1074\/jbc.M113.474650","article-title":"Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes","volume":"288","author":"Xu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib91","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1111\/jcmm.13802","article-title":"Melatonin activates Parkin translocation and rescues the impaired mitophagy activity of diabetic cardiomyopathy through Mst1 inhibition","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2020.604069","article-title":"Mitochondrial fission and mitophagy coordinately restrict high glucose toxicity in cardiomyocytes","volume":"11","author":"Kobayashi","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091232","article-title":"Effect of the non-immunosuppressive mpt pore inhibitor alisporivir on the functioning of heart mitochondria in dystrophin-deficient mdx mice","volume":"9","author":"Dubinin","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2023.115669_bib94","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.yjmcc.2011.03.002","article-title":"Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice","volume":"50","author":"Mellor","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib95","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.115669_bib96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbrc.2019.12.051","article-title":"Hyperglycemia-induced cardiomyocyte death is mediated by lysosomal membrane injury and aberrant expression of cathepsin D","volume":"523","author":"Kobayashi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115669_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fragi.2023.1113200","article-title":"Lysosomal dysfunction in diabetic cardiomyopathy","volume":"4","author":"Kobayashi","year":"2023","journal-title":"Front. Aging"},{"key":"10.1016\/j.biopha.2023.115669_bib98","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.7150\/ijbs.29680","article-title":"Metformin inhibits the NLRP3 inflammasome via AMPK\/mTOR-dependent effects in diabetic cardiomyopathy","volume":"15","author":"Yang","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2018.00383","article-title":"Mangiferin enhanced autophagy via inhibiting mTORC1 pathway to prevent high glucose-induced cardiomyocyte injury","volume":"9","author":"Hou","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib100","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db12-0533","article-title":"Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes","volume":"62","author":"He","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib101","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"R","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2023.115669_bib102","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1172\/JCI44736","article-title":"Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells","volume":"121","author":"Kim","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.115669_bib103","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.bbadis.2016.10.021","article-title":"Sirt3 deficiency exacerbates diabetic cardiac dysfunction: Role of Foxo3A-Parkin-mediated mitophagy","volume":"1863","author":"Yu","year":"2017","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2023.115669_bib104","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.bbadis.2018.04.009","article-title":"Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting Parkin-dependent mitophagy","volume":"1865","author":"Wang","year":"2019","journal-title":"Biochim. Biophys. Acta - Mol. Basis Dis."},{"key":"10.1016\/j.biopha.2023.115669_bib105","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1080\/15548627.2019.1596482","article-title":"Deficiency of mitophagy receptor FUNDC1 impairs mitochondrial quality and aggravates dietary-induced obesity and metabolic syndrome","volume":"15","author":"Wu","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2023.115669_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154840","article-title":"FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis","volume":"122","author":"Pei","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2023.115669_bib107","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc8561","article-title":"FUNDC1 interacts with FBXL2 to govern mitochondrial integrity and cardiac function through an IP3R3-dependent manner in obesity","volume":"6","author":"Ren","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biopha.2023.115669_bib108","doi-asserted-by":"crossref","first-page":"H927","DOI":"10.1152\/ajpheart.00049.2016","article-title":"Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress","volume":"311","author":"Koncsos","year":"2016","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/cells11091572","article-title":"Multiomics Approach Reveals an Important Role of BNIP3 in Myocardial Remodeling and the Pathogenesis of Heart Failure with Reduced Ejection Fraction","volume":"11","author":"Chaanine","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115669_bib110","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1172\/JCI122035","article-title":"An alternative mitophagy pathway mediated by Rab9 protects the heart against ischemia","volume":"129","author":"Saito","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.115669_bib111","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI125980","article-title":"Ulk1\/Rab9-mediated alternative mitophagy confers cardioprotection during energy stress","volume":"129","author":"Dhingra","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.115669_bib112","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1080\/15548627.2022.2025573","article-title":"Alternative mitophagy is a major form of mitophagy in the chronically stressed heart","volume":"18","author":"Sadoshima","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2023.115669_bib113","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1161\/CIRCRESAHA.121.319377","article-title":"Alternative mitophagy protects the heart against obesity-associated cardiomyopathy","volume":"129","author":"Tong","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.115669_bib114","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1016\/S0021-9258(18)96046-1","article-title":"Biochemical adaptations in muscle","volume":"242","author":"Holloszy","year":"1967","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib115","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1534\/genetics.112.141267","article-title":"Mitochondrial protein synthesis, import, and assembly","volume":"192","author":"Fox","year":"2012","journal-title":"Genetics"},{"key":"10.1016\/j.biopha.2023.115669_bib116","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/febs.13820","article-title":"Mitochondrial biogenesis and clearance: a balancing act","volume":"284","author":"Ploumi","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2023.115669_bib117","doi-asserted-by":"crossref","first-page":"4892","DOI":"10.1111\/jcmm.15194","article-title":"Mitochondrial biogenesis: An update","volume":"24","author":"Popov","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib118","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","article-title":"A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis","volume":"92","author":"Puigserver","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2023.115669_bib119","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3945\/ajcn.110.001917","article-title":"Regulation of PGC-1\u03b1, a nodal regulator of mitochondrial biogenesis","volume":"93","author":"Fernandez-Marcos","year":"2011","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2023.115669_bib120","first-page":"1","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"2","author":"Kwilas","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2023.115669_bib121","doi-asserted-by":"crossref","first-page":"12017","DOI":"10.1073\/pnas.0705070104","article-title":"AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1\u03b1","volume":"104","author":"J\u00e4er","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115669_bib122","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/nature07813","article-title":"AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity","volume":"458","author":"Cant\u00f3","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115669_bib123","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.yjmcc.2011.01.008","article-title":"Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy","volume":"51","author":"Sundaresan","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib124","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2337\/db14-0325","article-title":"ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1\u03b1\/PPAR-\u03b1 signaling","volume":"64","author":"Khan","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib125","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.1074\/jbc.M414670200","article-title":"SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes","volume":"280","author":"Shi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2023.115669_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011707","article-title":"Sirtuin 3, a new target of PGC-1\u03b1, plays an important role in the suppression of ROS and mitochondrial biogenesis","volume":"5","author":"Kong","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2023.115669_bib127","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.mito.2013.04.002","article-title":"Dual control of mitochondrial biogenesis by sirtuin 1 and sirtuin 3","volume":"13","author":"Brenmoehl","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biopha.2023.115669_bib128","first-page":"92","article-title":"Role of calcium in the modulation of kinetics of synchronous and asynchronous quantal release at the neuromuscular junction","volume":"27","author":"Vasin","year":"2010","journal-title":"Biol. Membr."},{"key":"10.1016\/j.biopha.2023.115669_bib129","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1073\/pnas.1232352100","article-title":"An autoregulatory loop controls peroxisome proliferator-activated receptor \u03b3 coactivator 1\u03b1 expression in muscle","volume":"100","author":"Handschin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115669_bib130","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1073\/pnas.171184698","article-title":"Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor","volume":"98","author":"Knutti","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115669_bib131","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S1097-2765(01)00390-2","article-title":"Cytokine Stimulation of Energy Expenditure through p38 MAP Kinase Activation of PPAR\u03b3 Coactivator-1","volume":"8","author":"Puigserver","year":"2001","journal-title":"Mol. Cell."},{"key":"10.1016\/j.biopha.2023.115669_bib132","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bph.14878","article-title":"FOXO1 inhibition prevents renal ischemia\u2013reperfusion injury via cAMP-response element binding protein\/PPAR-\u03b3 coactivator-1\u03b1-mediated mitochondrial biogenesis","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib133","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semnephrol.2018.01.003","article-title":"The Role of Peroxisome Proliferator-Activated Receptor \u03b3 Coactivator 1\u03b1 (PGC-1\u03b1) in Kidney Disease","volume":"38","author":"Li","year":"2018","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.biopha.2023.115669_bib134","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/ki.2015.332","article-title":"The inflammatory cytokine TWEAK decreases PGC-1\u03b1 expression and mitochondrial function in acute kidney injury","volume":"89","author":"Ruiz-Andres","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.biopha.2023.115669_bib135","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1128\/MCB.25.4.1354-1366.2005","article-title":"Control of Mitochondrial Transcription Specificity Factors (TFB1M and TFB2M) by Nuclear Respiratory Factors (NRF-1 and NRF-2) and PGC-1 Family Coactivators","volume":"25","author":"Gleyzer","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib136","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1161\/CIRCRESAHA.119.316100","article-title":"A Critical Role for Estrogen-Related Receptor Signaling in Cardiac Maturation","volume":"126","author":"Sakamoto","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2023.115669_bib137","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI38331","article-title":"Myc controls transcriptional regulation of cardiac metabolism and mitochondrial biogenesis in response to pathological stress in mice","volume":"120","author":"Ahuja","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.115669_bib138","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/MCB.25.14.6225-6234.2005","article-title":"Myc Stimulates Nuclearly Encoded Mitochondrial Genes and Mitochondrial Biogenesis","volume":"25","author":"Li","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib139","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bcp.2015.06.032","article-title":"Pharmacological induction of mitochondrial biogenesis as a therapeutic strategy for the treatment of type 2 diabetes","volume":"98","author":"Zamora","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ng1180","article-title":"PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes","volume":"34","author":"Mootha","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.biopha.2023.115669_bib141","doi-asserted-by":"crossref","DOI":"10.1007\/s00395-013-0329-1","article-title":"Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPK- PGC-1\u03b1 signaling contributing to increased vulnerability in diabetic heart","volume":"108","author":"Yan","year":"2013","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib142","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1096\/fj.201901838R","article-title":"MiR-144 protects the heart from hyperglycemia-induced injury by regulating mitochondrial biogenesis and cardiomyocyte apoptosis","volume":"34","author":"Tao","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.115669_bib143","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1159\/000374021","article-title":"Exercise prevents cardiac injury and improves mitochondrial biogenesis in advanced diabetic cardiomyopathy with PGC-1\u03b1 and Akt activation","volume":"35","author":"Wang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2023.115669_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0811-7","article-title":"MiR-30c\/PGC-1\u03b2 protects against diabetic cardiomyopathy via PPAR\u03b1","volume":"18","author":"Yin","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib145","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbrc.2021.01.086","article-title":"Rosmarinic acid ameliorated cardiac dysfunction and mitochondrial injury in diabetic cardiomyopathy mice via activation of the SIRT1\/PGC-1\u03b1 pathway","volume":"546","author":"Diao","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115669_bib146","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.bbrc.2017.09.151","article-title":"Polydatin ameliorates diabetic cardiomyopathy via Sirt3 activation","volume":"493","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115669_bib147","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ijlh.12426","article-title":"Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study","volume":"38","author":"Palareti","year":"2016","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.biopha.2023.115669_bib148","doi-asserted-by":"crossref","unstructured":"L.M. Yu, X. Dong, X.D. Xue, S. Xu, X. Zhang, Y.L. Xu, Z.S. Wang, Y. Wang, H. Gao, Y.X. Liang, Y. Yang, H.S. Wang, Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6, 2021. https:\/\/doi.org\/10.1111\/jpi.12698.","DOI":"10.1111\/jpi.12698"},{"key":"10.1016\/j.biopha.2023.115669_bib149","first-page":"1","article-title":"Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving \u201cSIRT1 and PGC-1\u03b1","volume":"17","author":"Waldman","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-014-0118-7","article-title":"Cardiac contractile function and mitochondrial respiration in diabetes-related mouse models","volume":"13","author":"Marciniak","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib151","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000484680","article-title":"Propofol Through Upregulating Caveolin-3 Attenuates Post-Hypoxic Mitochondrial Damage and Cell Death in H9C2 Cardiomyocytes during Hyperglycemia","volume":"44","author":"Deng","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.biopha.2023.115669_bib152","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1530\/JOE-19-0081","article-title":"Glucagon regulates hepatic mitochondrial function and biogenesis through FOXO1","volume":"241","author":"Yang","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.biopha.2023.115669_bib153","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2023.115669_bib154","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling\/Autophagy Hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115669_bib155","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.117.030012","article-title":"Sodium glucose cotransporter-2 inhibition in heart failure: Potential mechanisms, clinical applications, and summary of clinical trials","volume":"136","author":"Lytvyn","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115669_bib156","first-page":"17","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"13","author":"Steiner","year":"2016","journal-title":"Z. Fur Gefass"},{"key":"10.1016\/j.biopha.2023.115669_bib157","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib158","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/CIRCULATIONAHA.117.032038","article-title":"Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study","volume":"137","author":"Mahaffey","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115669_bib159","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(13)60683-2","article-title":"Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial","volume":"382","author":"Cefalu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115669_bib161","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/dc16-2427","article-title":"Coadministration of canagliflozin and phentermine for weight management in overweight and obese individuals without diabetes: A randomized clinical trial","volume":"40","author":"Hollander","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2023.115669_bib162","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib163","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1056\/NEJMc1902636","article-title":"Marine n\u20133 Fatty Acids and Vitamin D Supplementation and Primary Prevention","volume":"380","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0745-5","article-title":"Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors","volume":"17","author":"Lahnwong","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib165","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","article-title":"Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission","volume":"15","author":"Zhou","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175531","article-title":"Empagliflozin ameliorates cardiac dysfunction in heart failure mice via regulating mitochondrial dynamics","volume":"942","author":"Lyu","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0964-4","article-title":"Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats","volume":"18","author":"Shao","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib168","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/cvr\/cvad009","article-title":"Empagliflozin inhibits excessive autophagy through the AMPK\/GSK3\u03b2 signalling pathway in diabetic cardiomyopathy","volume":"119","author":"Madonna","year":"2023","journal-title":"Cardiovasc. Res"},{"key":"10.1016\/j.biopha.2023.115669_bib169","article-title":"Attenuation of adverse postinfarction left ventricular remodeling with empagliflozin enhances mitochondria-linked cellular energetics and mitochondrial biogenesis","volume":"23","author":"Song","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14814\/phy2.13741","article-title":"Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts","volume":"6","author":"Mizuno","year":"2018","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102288","article-title":"Empagliflozin attenuates cardiac microvascular ischemia\/reperfusion through activating the AMPK\u03b11\/ULK1\/FUNDC1\/mitophagy pathway","volume":"52","author":"Cai","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib172","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1152\/ajpheart.00932.2010","article-title":"Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways","volume":"300","author":"Anderson","year":"2011","journal-title":"Am. J. Physiol. - Hear. Circ. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib173","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00125-016-4134-x","article-title":"Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+\/H+ exchanger in rats and rabbits","volume":"60","author":"Baartscheer","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2023.115669_bib174","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10557-018-6837-3","article-title":"Dapagliflozin Attenuates Na+\/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation","volume":"32","author":"Ye","year":"2018","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2023.115669_bib175","article-title":"Empagliflozin attenuates myocardial sodium and calcium dysregulation and reverses cardiac remodeling in streptozotocin-induced diabetic rats","volume":"20","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib176","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10557-017-6734-1","article-title":"Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes","volume":"31","author":"Hammoudi","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.biopha.2023.115669_bib177","series-title":"Empagliflozin improves diabetic renal tubular injury by alleviating mitochondrial fission via AMPK\/SP1\/PGAM5 pathway","author":"Liu","year":"2020"},{"key":"10.1016\/j.biopha.2023.115669_bib178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0980-4","article-title":"Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy","volume":"19","author":"Arow","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib179","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nm.3828","article-title":"Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion","volume":"21","author":"Bonner","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib180","first-page":"1340","article-title":"Glucagon","volume":"56","author":"David","year":"1975","journal-title":"Regulation"},{"key":"10.1016\/j.biopha.2023.115669_bib181","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2337\/diab.32.5.387","article-title":"Role of glucagon in enhancing ketone body production in ketotic diabetic man","volume":"32","author":"Keller","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib182","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1096\/fj.11-200410","article-title":"Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet","volume":"26","author":"Srivastava","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2023.115669_bib183","unstructured":"P. Tanajak, P. Sa-nguanmoo, S. Sivasinprasasn, S. Thummasorn, N. Siri-Angkul, S.C. Chattipakorn, N. Chattipakorn, Cardioprotection of dapagliflozin and vildagliptin in cardiac reperfusion injury rats, 2, 2013: 1\u201345."},{"key":"10.1016\/j.biopha.2023.115669_bib184","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0790-0","article-title":"A SGLT2 inhibitor dapagliflozin suppresses prolonged ventricular-repolarization through augmentation of mitochondrial function in insulin-resistant metabolic syndrome rats","volume":"17","author":"Durak","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib185","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01119-z","article-title":"Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels","volume":"19","author":"Zuurbier","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01066-9","article-title":"Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia\/reperfusion injury","volume":"19","author":"Lahnwong","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib187","article-title":"Canagliflozin Attenuates Lipotoxicity in Cardiomyocytes by Inhibiting Inflammation and Ferroptosis through Activating AMPK Pathway","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2022.1011669","article-title":"Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy","volume":"13","author":"Du","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.biopha.2023.115669_bib189","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/21623945.2020.1807850","article-title":"The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1\u03b1 signalling pathway","volume":"9","author":"Yang","year":"2020","journal-title":"Adipocyte"},{"key":"10.1016\/j.biopha.2023.115669_bib190","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019995","article-title":"Effects of sodium-glucose linked transporter 2 inhibition with ertugliflozin on mitochondrial function, energetics, and metabolic gene expression in the presence and absence of diabetes mellitus in mice","volume":"10","author":"Croteau","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2023.115669_bib191","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jdi.12802","article-title":"Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high-fat diet","volume":"9","author":"Takagi","year":"2018","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.biopha.2023.115669_bib192","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41574-018-0016-2","article-title":"Glucagon-like peptide 1 in health and disease","volume":"14","author":"Andersen","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.biopha.2023.115669_bib193","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1148209","article-title":"Glucagon-like peptide-1: a multi-faceted anti-inflammatory agent","volume":"14","author":"Mehdi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115669_bib194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: Current and future therapies. Beyond glycemic control","volume":"9","author":"Borghetti","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib195","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1177\/0004563216663075","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"53","author":"Jones","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.biopha.2023.115669_bib196","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib197","first-page":"1","article-title":"Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: Randomized placebo-controlled trial","volume":"18","author":"Bizino","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib198","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115669_bib199","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/ejhf.2670","article-title":"Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post-hoc analysis from the REWIND randomized trial","volume":"24","author":"Branch","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.biopha.2023.115669_bib200","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.atherosclerosis.2019.07.007","article-title":"Liraglutide in combination with metformin may improve the atherogenic lipid profile and decrease C-reactive protein level in statin treated obese patients with coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial","volume":"288","author":"Anholm","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.biopha.2023.115669_bib201","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/dom.13761","article-title":"Effect of liraglutide on estimates of lipolysis and lipid oxidation in obese patients with stable coronary artery disease and newly diagnosed type 2 diabetes: A randomized trial","volume":"21","author":"Anholm","year":"2019","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.biopha.2023.115669_bib202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines11030869","article-title":"Real-World Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist, Dulaglutide, on Metabolic Parameters in Japanese Patients with Type 2 Diabetes: A Retrospective Longitudinal Study","volume":"11","author":"Katsuyama","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2023.115669_bib203","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.7150\/ijbs.59965","article-title":"Glp-1 receptor agonists (Glp-1ras): Cardiovascular actions and therapeutic potential","volume":"17","author":"Ma","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib204","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bph.13549","article-title":"Glucagon-like peptide-1 receptor signalling reduces microvascular thrombosis, nitro-oxidative stress and platelet activation in endotoxaemic mice","volume":"174","author":"Steven","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/joim.12890","article-title":"Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists","volume":"286","author":"Bonaventura","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.biopha.2023.115669_bib207","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5396806","article-title":"Exendin-4 and liraglutide attenuate glucose toxicity-induced cardiac injury through mTOR\/ULK1-dependent autophagy","volume":"2018","author":"Yu","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115669_bib208","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.mce.2017.03.029","article-title":"Liraglutide relieves myocardial damage by promoting autophagy via AMPK-mTOR signaling pathway in zucker diabetic fatty rat","volume":"448","author":"Zhang","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2023.115669_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111560","article-title":"Liraglutide prevents high glucose induced HUVECs dysfunction via inhibition of PINK1\/Parkin-dependent mitophagy","volume":"545","author":"Zhang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2023.115669_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175048","article-title":"Suppression of angiotensin II-activated NOX4\/NADPH oxidase and mitochondrial dysfunction by preserving glucagon-like peptide-1 attenuates myocardial fibrosis and hypertension","volume":"927","author":"Banks","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib211","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/1440-1681.13590","article-title":"Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca2+ abnormalities and mitochondrial dysfunc","volume":"49","author":"Durak","year":"2022","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib212","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12640-021-00460-9","article-title":"Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1\u03b1 in a Mouse Model of Parkinson\u2019s Disease","volume":"40","author":"Wu","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.biopha.2023.115669_bib213","article-title":"Glucagon-like peptide-1 receptor agonist attenuates autophagy to ameliorate pulmonary arterial hypertension through Drp1\/NOXand Atg-5\/Atg-7\/Beclin-1\/LC3\u03b2 pathways","volume":"20","author":"Wu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib214","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.bbrc.2018.11.135","article-title":"Lixisenatide enhances mitochondrial biogenesis and function through regulating the CREB\/PGC-1\u03b1 pathway","volume":"508","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115669_bib215","first-page":"1","article-title":"Glucagon-like Peptide 1 Receptor Activation Inhibits Microglial Pyroptosis via Promoting Mitophagy to Alleviate Depression-like Behaviors in Diabetic Mice","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.115669_bib216","doi-asserted-by":"crossref","unstructured":"M. Kobara, H. Toba, T. Nakata, A. Glucagon-like Peptide 1 Analog Protects Mitochondria and Attenuates Hypoxia-Reoxygenation Injury in Cultured Cardiomyocytes, 2022. https:\/\/doi.org\/10.1097\/FJC.0000000000001218.","DOI":"10.1097\/FJC.0000000000001218"},{"key":"10.1016\/j.biopha.2023.115669_bib217","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4077\/CJP.2017.BAF434","article-title":"Attenuation of high glucose-induced rat cardiomyocyte apoptosis by exendin-4 via intervention of HO-1\/Nrf-2 and the PI3K\/AKT signaling pathway","volume":"60","author":"Zhao","year":"2017","journal-title":"Chin. J. Physiol."},{"key":"10.1016\/j.biopha.2023.115669_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110218","article-title":"Downregulation of the GLP-1\/CREB\/adiponectin pathway is partially responsible for diabetes-induced dysregulated vascular tone and VSMC dysfunction","volume":"127","author":"Xiong","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115669_bib219","doi-asserted-by":"crossref","unstructured":"G. Naruse, H. Kanamori, A. Yoshida, S. Minatoguchi, T. Kawaguchi, M. Iwasa, Y. Yamada, A. Mikami, M. Kawasaki, K. Nishigaki, S. Minatoguchi, The intestine responds to heart failure by enhanced mitochondrial fusion through glucagon-like peptide-1 signalling, 2019. https:\/\/doi.org\/10.1093\/cvr\/cvz002.","DOI":"10.1093\/cvr\/cvz002"},{"key":"10.1016\/j.biopha.2023.115669_bib220","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1463-1326.2010.01238.x","article-title":"Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: Potential involvement of AKT and mitochondria biogenesis","volume":"12","author":"Fan","year":"2010","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.biopha.2023.115669_bib221","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3803\/EnM.2015.30.2.216","article-title":"Glucagon-like peptide-1 increases mitochondrial biogenesis and function in INS-1 rat insulinoma cells","volume":"30","author":"Kang","year":"2015","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2023.115669_bib222","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026728","article-title":"Long-Term Activation of Glucagon-like peptide-1 receptor by Dulaglutide Prevents Diabetic Heart Failure and Metabolic Remodeling in Type 2 Diabetes","volume":"11","author":"Xie","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2023.115669_bib223","first-page":"157","article-title":"Semaglutide is neuroprotective and reduces \u03b1-synuclein levels in the chronic MPTP mouse model of Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2019","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.biopha.2023.115669_bib224","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cbf.3795","article-title":"The cardioprotective effect of human glucagon-like peptide-1 receptor agonist (semaglutide) on cisplatin-induced cardiotoxicity in rats: Targeting mitochondrial functions, dynamics, biogenesis, and redox status pathways","volume":"41","author":"Atef","year":"2023","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.biopha.2023.115669_bib225","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115669_bib226","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jamda.2015.10.009","article-title":"Cardiovascular Outcomes of Dipeptidyl Peptidase-4 Inhibitors in Elderly Patients With Type 2 Diabetes: A Nationwide Study","volume":"17","author":"Shih","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.biopha.2023.115669_bib227","article-title":"Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: Systematic review and meta-analysis of randomised and observational studies","volume":"352","author":"Li","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.biopha.2023.115669_bib228","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijcard.2016.02.146","article-title":"Effect of dipeptidyl peptidase-4 inhibitors on heart failure: A meta-analysis of randomized clinical trials","volume":"211","author":"Kongwatcharapong","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib229","doi-asserted-by":"crossref","first-page":"E152","DOI":"10.9778\/cmajo.20160058","article-title":"Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis","volume":"5","author":"Verma","year":"2017","journal-title":"C. Open."},{"key":"10.1016\/j.biopha.2023.115669_bib230","article-title":"Dipeptidyl peptidase-4 inhibitors and risk of heart failure in patients with type 2 diabetes mellitus: A population-based cohort study","volume":"10","author":"Kim","year":"2017","journal-title":"Circ. Hear. Fail."},{"key":"10.1016\/j.biopha.2023.115669_bib231","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2337\/dc14-2868","article-title":"Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial","volume":"38","author":"Leiter","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2023.115669_bib232","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0140-6736(14)62225-X","article-title":"Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: A multicentre, randomised, double-blind trial","volume":"385","author":"Zannad","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115669_bib233","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib234","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.112.195115","article-title":"Dipeptidyl peptidase 4 inhibitor sitagliptin protects endothelial function in hypertension through a glucagon-like peptide 1-dependent mechanism","volume":"60","author":"Liu","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.biopha.2023.115669_bib235","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.07.053","article-title":"A dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin, improves endothelial function and reduces atherosclerotic lesion formation in apolipoprotein edeficient mice","volume":"59","author":"Matsubara","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib236","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrcardio.2012.183","article-title":"Cardiovascular effects of gliptins","volume":"10","author":"Scheen","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2023.115669_bib237","doi-asserted-by":"crossref","DOI":"10.1007\/s40618-023-02014-6","article-title":"A novel combination of sitagliptin and melatonin ameliorates T2D manifestations: studies on experimental diabetic models","author":"Patel","year":"2023","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.biopha.2023.115669_bib238","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/iub.2076","article-title":"Sitagliptin promotes mitochondrial biogenesis in human SH-SY5Y cells by increasing the expression of PGC-1\u03b1\/NRF1\/TFAM","volume":"71","author":"Weng","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2023.115669_bib239","first-page":"1","article-title":"This is an Accepted Article that has been peer-reviewed and approved for publication in the Journal of Gastroenterology and Hepatology, but has yet to undergo copy-editing and proof correction. Please cite this article as an \u201c Accepted Article \u201d","author":"Unit","year":"2011","journal-title":"Mortality"},{"key":"10.1016\/j.biopha.2023.115669_bib240","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/bph.12176","article-title":"Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats","volume":"169","author":"Apaijai","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib241","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00210-019-01660-z","article-title":"Pretreatment with vildagliptin boosts ischemic-postconditioning effects on cardioprotection and expression profile of genes regulating autophagy and mitochondrial fission\/fusion in diabetic heart with reperfusion injury","volume":"392","author":"Pirzeh","year":"2019","journal-title":"Naunyn. Schmiede Arch. Pharm."},{"key":"10.1016\/j.biopha.2023.115669_bib242","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/jcmm.13975","article-title":"Vildagliptin improves high glucose-induced endothelial mitochondrial dysfunction via inhibiting mitochondrial fission","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med"},{"key":"10.1016\/j.biopha.2023.115669_bib243","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.117.005945","article-title":"Alogliptin, a dipeptidyl peptidase-4 inhibitor, alleviates atrial remodeling and improves mitochondrial function and biogenesis in diabetic rabbits","volume":"6","author":"Zhang","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.biopha.2023.115669_bib244","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-018-0803-z","article-title":"Alogliptin prevents diastolic dysfunction and preserves left ventricular mitochondrial function in diabetic rabbits","volume":"17","author":"Zhang","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/acel.12883","article-title":"Alogliptin improves survival and health of mice on a high-fat diet","volume":"18","author":"Zhu","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.biopha.2023.115669_bib246","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s12276-023-00958-6","article-title":"Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db\/db mice","volume":"55","author":"Pham","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib247","doi-asserted-by":"crossref","DOI":"10.1111\/jdi.14017","article-title":"Linagliptin ameliorated cardiac fibrosis and restored cardiomyocyte structure in diabetic mice associated with the suppression of necroptosis","volume":"14","author":"Adhikari","year":"2023","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.biopha.2023.115669_bib248","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2018.08.062","article-title":"Linagliptin improved myocardial function recovery in rat hearts after a prolonged hypothermic preservation","volume":"210","author":"Gen","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib249","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.freeradbiomed.2020.07.030","article-title":"High glucose-induced PRDX3 acetylation contributes to glucotoxicity in pancreatic \u03b2-cells: Prevention by Teneligliptin","volume":"160","author":"Elumalai","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib250","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s13577-021-00594-0","article-title":"Trelagliptin ameliorates oxygen\u2013glucose deprivation\/reperfusion (OGD\/R)-induced mitochondrial dysfunction and metabolic disturbance of endothelial cells","volume":"34","author":"Zhang","year":"2021","journal-title":"Hum. Cell."},{"key":"10.1016\/j.biopha.2023.115669_bib251","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-019-1270-y","article-title":"Thiazolidinediones: the Forgotten Diabetes Medications","volume":"19","author":"Lebovitz","year":"2019","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib252","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/1574886315666201026125530","article-title":"Efficacy and Cardiovascular Safety of Thiazolidinediones","volume":"16","author":"Raveendran","year":"2020","journal-title":"Curr. Drug Saf."},{"key":"10.1016\/j.biopha.2023.115669_bib253","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehm529","article-title":"Weighing up the cardiovascular benefits of thiazolidinedione therapy: The impact of increased risk of heart failure","volume":"29","author":"Erdmann","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2023.115669_bib254","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(07)61514-1","article-title":"Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes \u2026","author":"Lago","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115669_bib255","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.2337\/dc20-S010","article-title":"Cardiovascular disease and risk management: Standards of medical care in diabetes- 2020","volume":"43","author":"Care","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2023.115669_bib256","doi-asserted-by":"crossref","unstructured":"B. Bozkurt, D. Aguilar, A. Deswal, S.B. Dunbar, G.S. Francis, T. Horwich, M. Jessup, M. Kosiborod, A.M. Pritchett, K. Ramasubbu, C. Rosendorff, C. Yancy, Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association, 2016. https:\/\/doi.org\/10.1161\/CIR.0000000000000450.","DOI":"10.1161\/CIR.0000000000000450"},{"key":"10.1016\/j.biopha.2023.115669_bib257","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1479164118825376","article-title":"Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes","volume":"16","author":"DeFronzo","year":"2019","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"2019","key":"10.1016\/j.biopha.2023.115669_bib258","first-page":"139","article-title":"Individual differences in corticolimbic structural profiles linked to insecure attachment and coping styles in motor functional ne, \u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"Williams","year":"2018","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2023.115669_bib259","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-021-01294-7","article-title":"Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug","volume":"20","author":"Nesti","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib260","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/eji.1830130711","article-title":"Genetic control of the response of chicken T lymphocytes to concanavalin A: cellular localization of the low responder defect","volume":"13","author":"Pink","year":"1983","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2023.115669_bib261","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.eclinm.2018.09.006","article-title":"Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patien","volume":"4\u20135","author":"Asakura","year":"2018","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.biopha.2023.115669_bib262","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S2213-8587(17)30317-0","article-title":"Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial","volume":"5","author":"Vaccaro","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2023.115669_bib263","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0617-4","article-title":"Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials","volume":"16","author":"de Jong","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib264","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013927","article-title":"Pioglitazone and cardiovascular outcomes in patients with insulin resistance, pre-diabetes and type 2 diabetes: A systematic review and meta-analysis","volume":"7","author":"Liao","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.biopha.2023.115669_bib265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bbrc.2008.11.141","article-title":"TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis","volume":"379","author":"Fujisawa","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115669_bib266","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/diabetes.54.5.1392","article-title":"Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue in vivo","volume":"54","author":"Bogacka","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib267","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174218","article-title":"Peroxisome proliferator-activated receptor agonist (pioglitazone) with exogenous adiponectin ameliorates arterial stiffness and oxidative stress in diabetic Wistar Kyoto rats","volume":"907","author":"Afzal","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115669_bib268","first-page":"1","article-title":"Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-\u03b3\/PGC-1\u03b1 Signaling Pathway","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharm."},{"key":"10.1016\/j.biopha.2023.115669_bib269","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4161\/auto.6458","article-title":"Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress: Implications for Parkinson\u2019s disease","volume":"4","author":"Dagda","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2023.115669_bib270","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.2337\/db06-1135","article-title":"Adipose mitochondrial biogenesis is suppressed in db\/db and high-fat diet-fed mice and improved by rosiglitazone","volume":"56","author":"Rong","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib271","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI21752","article-title":"Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone","volume":"114","author":"Wilson-Fritch","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2023.115669_bib272","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/db10-0281","article-title":"FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction","volume":"60","author":"Bravard","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib273","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2023.115669_bib274","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1161\/CIRCULATIONAHA.117.031735","article-title":"Repurposing Metformin for Cardiovascular Disease","volume":"137","author":"Rena","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115669_bib275","doi-asserted-by":"crossref","first-page":"26438","DOI":"10.1073\/pnas.2009838117","article-title":"Metformin rescues Parkinson\u2019s disease phenotypes caused by hyperactive mitochondria","volume":"117","author":"Mor","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2023.115669_bib276","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","article-title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer\u2019s disease risk in the general population: a Mendelian randomisation study","volume":"65","author":"Zheng","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.biopha.2023.115669_bib277","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in cancer treatment and prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib278","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2020.00191","article-title":"Metformin and Its Benefits for Various Diseases","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)."},{"key":"10.1016\/j.biopha.2023.115669_bib279","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/dom.13642","article-title":"Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease","volume":"21","author":"Charytan","year":"2019","journal-title":"Diabetes, Obes. Metab."},{"key":"10.1016\/j.biopha.2023.115669_bib280","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2337\/diacare.25.3.542","article-title":"Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes","volume":"25","author":"Chu","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2023.115669_bib281","first-page":"1998","volume":"352","author":"We","year":"1998","journal-title":"Authors \u2019 Reply"},{"key":"10.1016\/j.biopha.2023.115669_bib282","first-page":"597","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","volume":"5","author":"Petrie","year":"2017"},{"key":"10.1016\/j.biopha.2023.115669_bib283","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2023.115669_bib284","doi-asserted-by":"crossref","first-page":"246.e1","DOI":"10.1016\/j.ajog.2020.01.054","article-title":"Metformin use in obese mothers is associated with improved cardiovascular profile in the offspring","volume":"223","author":"Panagiotopoulou","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.biopha.2023.115669_bib285","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1093\/eurheartj\/ehz203","article-title":"A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: The MET-REMODEL trial","volume":"40","author":"Mohan","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2023.115669_bib286","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108798","article-title":"Effects of omega-3 fatty acids and metformin combination on diabetic cardiomyopathy in rats through autophagic pathway","volume":"97","author":"Eraky","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2023.115669_bib287","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2337\/db10-0351","article-title":"Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice","volume":"60","author":"Xie","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib288","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1111\/jcmm.14834","article-title":"Metformin upregulates mitophagy in patients with T2DM: A randomized placebo-controlled study","volume":"24","author":"Bhansali","year":"2020","journal-title":"J. Cell. Mol. Med"},{"key":"10.1016\/j.biopha.2023.115669_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102342","article-title":"Metformin modulates mitochondrial function and mitophagy in peripheral blood mononuclear cells from type 2 diabetic patients","volume":"53","author":"de Mara\u00f1\u00f3n","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib290","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.3892\/mmr.2020.11599","article-title":"Metformin protects high glucose-cultured cardiomyocytes from oxidative stress by promoting NDUFA13 expression and mitochondrial biogenesis via the AMPK signaling pathway","volume":"22","author":"Liu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.biopha.2023.115669_bib291","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/db16-0915","article-title":"Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission","volume":"66","author":"Wang","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.biopha.2023.115669_bib292","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"Palinkas","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2023.115669_bib293","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/ars.2021.0019","article-title":"Does Metformin Modulate Mitochondrial Dynamics and Function in Type 2 Diabetic Patients?","volume":"35","author":"De Mara\u00f1\u00f3n","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2023.115669_bib294","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0499-5","article-title":"Cardiovascular safety of non-insulin pharmacotherapy for type 2 diabetes","volume":"16","author":"Xu","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib295","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115669_bib296","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0933-y","article-title":"Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes","volume":"18","author":"Coleman","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib297","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-8587(17)30309-1","article-title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Holman","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.biopha.2023.115669_bib298","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.ahj.2003.11.020","article-title":"Impaired glucose tolerance and cardiovascular disease: The possible role of post-prandial hyperglycemia","volume":"147","author":"Ceriello","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.biopha.2023.115669_bib299","first-page":"266","article-title":"Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance","volume":"12","author":"Schneider","year":"2003","journal-title":"Diabetes Und Stoffwechs."},{"key":"10.1016\/j.biopha.2023.115669_bib300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0195-668X(03)00468-8","article-title":"Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies","volume":"25","author":"Hanefeld","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2023.115669_bib301","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.metabol.2006.01.016","article-title":"An \u03b1-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients","volume":"55","author":"Satoh","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2023.115669_bib302","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.metabol.2013.12.014","article-title":"Cotreatment with the \u03b1-glucosidase inhibitor miglitol and DPP-4 inhibitor sitagliptin improves glycemic control and reduces the expressions of CVD risk factors in type 2 diabetic Japanese patients","volume":"63","author":"Imai","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.biopha.2023.115669_bib303","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-6-20","article-title":"Cardiovascular benefits and safety profile of acarbose therapy in prediabetes and established type 2 diabetes","volume":"6","author":"Hanefeld","year":"2007","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib304","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/cpt.2877","article-title":"Mitochondrial DNA Copy Number Is a Potential Biomarker for Treatment Choice Between Metformin and Acarbose","volume":"113","author":"Wang","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2023.115669_bib305","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1254\/jphs.12108FP","article-title":"Miglitol, an anti-diabetic drug, inhibits oxidative stress-induced apoptosis and mitochondrial ROS over-production in endothelial cells by enhancement of amp-activated protein Kinase","volume":"120","author":"Aoki","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib306","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.bbrc.2013.12.120","article-title":"Voglibose administration regulates body weight and energy intake in high fat-induced obese mice","volume":"443","author":"Do","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2023.115669_bib307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jpi.12491","article-title":"Melatonin prevents Drp1-mediated mitochondrial fission in diabetic hearts through SIRT1-PGC1\u03b1 pathway","volume":"65","author":"Ding","year":"2018","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.biopha.2023.115669_bib308","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102098","article-title":"Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2\u03b1-Stat3 pathway in diabetic cardiomyopathy","volume":"46","author":"Liu","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.115669_bib309","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1002\/ptr.7175","article-title":"Salidroside protects cardiac function in mice with diabetic cardiomyopathy via activation of mitochondrial biogenesis and SIRT3","volume":"35","author":"Li","year":"2021","journal-title":"Phyther. Res."},{"key":"10.1016\/j.biopha.2023.115669_bib310","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/aps.2017.50","article-title":"Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1\u03b1 deacetylation","volume":"39","author":"Fang","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2023.115669_bib311","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2016.06.008","article-title":"Metformin and resveratrol inhibit Drp1-mediated mitochondrial fission and prevent ER stress-associated NLRP3 inflammasome activation in the adipose tissue of diabetic mice","volume":"434","author":"Li","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.biopha.2023.115669_bib312","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/ars.2020.8248","article-title":"Punicalagin Protects against Diabetic Cardiomyopathy by Promoting Opa1-Mediated Mitochondrial Fusion via Regulating PTP1B-Stat3 Pathway","volume":"35","author":"Fu","year":"2021","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2023.115669_bib313","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21\u2013Sirtuin 3 Axis Confers the Protective Effects of Exercise Against Diabetic Cardiomyopathy by Governing Mitochondrial Integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115669_bib314","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00109-019-01861-2","article-title":"Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy","volume":"98","author":"Wang","year":"2020","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib315","first-page":"627","volume":"466","author":"Marcheva","year":"2011","journal-title":"Pancreat. CLOCK BMAL1"},{"key":"10.1016\/j.biopha.2023.115669_bib316","first-page":"E15","article-title":"Bmal1-downregulation aggravates porphyromonas gingivalis-induced atherosclerosis by encouraging oxidative stress","author":"Xie","year":"2020","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.115669_bib317","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2023.1142512","article-title":"The role of circadian clock-controlled mitochondrial dynamics in diabetic cardiomyopathy","volume":"14","author":"Jin","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115669_bib318","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2022.01.028","article-title":"Protective role of hydrogen sulfide against diabetic cardiomyopathy via alleviating necroptosis","volume":"181","author":"Gong","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115669_bib319","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202202590","article-title":"Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent Inflammation","volume":"9","author":"Luo","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2023.115669_bib320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-022-01643-0","article-title":"Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK\/mTOR signalling pathway","volume":"21","author":"Wang","year":"2022","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.biopha.2023.115669_bib321","article-title":"Empagliflozin ameliorates diabetic cardiomyopathy via attenuating oxidative stress and improving mitochondrial function","volume":"2022","author":"Wang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2023.115669_bib322","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.mito.2021.06.008","article-title":"Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL\/6NCrl mice with high-fat diet\/streptozotocin-induced diabetes mellitus","volume":"59","author":"Belosludtsev","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.biopha.2023.115669_bib323","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS Public Access","volume":"176","author":"Jiska Cohen-Mansfield","year":"2017","journal-title":"Physiol. Behav."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223014671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:44:21Z","timestamp":1779918261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223014671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":323,"alternative-id":["S0753332223014671"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115669","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mitochondrial quality control for diabetic cardiomyopathy: Therapeutic potential of hypoglycemic drugs","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115669","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115669"}}